Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine1A receptor-mediated feedback: a microdialysis study in the amygdala
| Autor: | Minke E. Jongsma, den Johan Boer, Ben H.C. Westerink, Håkan Wikström, Thomas I. F. H. Cremers, Fokko J. Bosker |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Agonist
medicine.medical_specialty Microdialysis business.industry medicine.drug_class Citalopram Receptor antagonist Biochemistry Cellular and Molecular Neuroscience Endocrinology nervous system Postsynaptic potential Internal medicine Flesinoxan mental disorders medicine 5-HT1A receptor business Reuptake inhibitor medicine.drug |
| Zdroj: | Journal of Neurochemistry. 76:1645-1653 |
| ISSN: | 0022-3042 |
| DOI: | 10.1046/j.1471-4159.2001.00194.x |
| Popis: | Microdialysis was used to assess the involvement of postsynaptic 5-hydroxytryptamine(1A) (5-HT1A) receptors in the regulation of extracellular 5-HT in the amygdala. Local infusion of the 5-HT1A receptor agonist flesinoxan (0.3, 1, 3 muM) for 30 min into the amygdala maximally decreased 5-HT to 50% of basal level. Systemic administration of citalopram (10 mu mol/kg) increased 5-HT to 175% of basal revel. Local infusion of 1 muM of the 5-HT1A receptor antagonist WAY 100.635 into the amygdala augmented the effect of citalopram to more than 500% of basal 5-HT level. 5-HT1A receptor responsiveness after chronic citalopram treatment was determined in two ways. First, by local infusion of 1 muM flesinoxan for 30 min into the amygdala, which showed a significant 63% reduction in response (area under the concentration-time curve; AUC) for the citalopram group compared to the saline group. Second, by systemic administration of citalopram (10 mu mol/kg), which increased 5-HT to 350% of basal level. The effect was larger than in untreated animals, but more important, local infusion of 1 muM WAY 100.635 into the amygdala now failed to augment the effect of citalopram. Both the flesinoxan and WAY 100.635 data suggest an involvement of postsynaptic 5-HT1A receptor-mediated feedback in the amygdala, which diminishes following chronic citalopram treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text